ROSEN, LEADING LITIGATION ATTORNEYS, Encourages DexCom, Inc. Investors to Retain Counsel Ahead of Key Deadline in Securities Class Action – DXCM

New York, New York–(Newsfile Corp. – September 7, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of DexCom, Inc. (NASDAQ: DXCM) securities between January 8, 2024 and July 25, 2024, both dates inclusive (the “Class Period”), of the important Deadline for Lead Plaintiffs October 21, 2024 in the securities class action lawsuit.

SO WHAT: If you purchased DexCom securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a success fee arrangement.